bf/NASDAQ:CNTX_icon.jpeg

NASDAQ:CNTX

Context Therapeutics Inc.

  • Stock

USD

Last Close

1.71

15/05 20:00

Market Cap

126.75M

Beta: -

Volume Today

231.62K

Avg: 99.97K

PE Ratio

−0.80

PFCF: −0.90

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
9.27K
-
12.04K
29.95%
gross profit
-9.27K
-
-12.04K
29.95%
selling and marketing expenses
-12.04K
-
general and administrative expenses
2.97M
-
930.67K
68.61%
3.63M
290.36%
7.79M
114.43%
7.29M
6.42%
selling general and administrative expenses
2.97M
-
930.67K
68.61%
3.63M
290.36%
7.79M
114.43%
7.28M
6.58%
research and development expenses
2.41M
-
1.64M
31.94%
3.81M
131.80%
7.09M
86.36%
17.78M
150.77%
other expenses
93.36K
-
9.88M
10,479.83%
123.87K
98.75%
-2.00K
101.62%
cost and expenses
5.38M
-
2.57M
52.16%
7.44M
189.17%
14.88M
100.07%
25.07M
68.49%
operating expenses
5.38M
-
2.57M
52.16%
7.44M
189.17%
14.88M
100.07%
25.06M
68.40%
interest expense
1.10M
-
661.22K
39.91%
64.24K
90.28%
547.27K
751.91%
ebitda
-5.38M
-
-2.57M
52.16%
-7.31M
184.36%
-14.37M
96.50%
-25.06M
74.37%
operating income
-5.38M
-
-2.57M
52.16%
-10.53M
309.22%
-15.38M
46.13%
-25.07M
63.01%
depreciation and amortization
5.38K
-
2.57K
52.16%
3.21M
124,763.69%
1.01M
68.58%
12.04K
98.81%
total other income expenses net
-1.01M
-
9.22M
1,015.23%
68.95K
99.25%
545.26K
690.82%
1.11M
103.28%
income before tax
-6.38M
-
6.64M
204.08%
-10.46M
257.38%
-14.84M
41.88%
-23.96M
61.53%
income tax expense
1.10M
-
661.22K
39.91%
-3.02M
557.27%
-545.26K
81.97%
-4
100.00%
net income
-7.48M
-
6.64M
188.78%
-7.43M
211.87%
-14.29M
92.25%
-23.96M
67.69%
weighted average shs out
10.96M
-
10.96M
0%
15.97M
45.68%
15.97M
0%
15.97M
0%
weighted average shs out dil
10.96M
-
10.96M
0%
15.97M
45.68%
15.97M
0%
15.97M
0%
eps
-0.68
-
0.61
189.71%
-0.47
177.05%
-0.90
91.49%
-1.50
66.67%
epsdiluted
-0.68
-
0.61
189.71%
-0.47
177.05%
-0.90
91.49%
-1.50
66.67%

All numbers in USD (except ratios and percentages)